查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1572044

主動脈瓣狹窄市場：按瓣膜類型、手術類型、最終用戶分類 - 2025-2030 年全球預測

Aortic Stenosis Market by Valve Type (Mechanical Valves, Tissue Valves), Surgery Type (Minimally Invasive Surgery, Open Heart Surgery), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

主動脈瓣狹窄市場2023年估值為82.3億美元，預計到2024年將達到89.9億美元，複合年成長率為9.63%，預計到2030年將達到156.7億美元。

主動脈瓣狹窄（AS）是一種心血管疾病，其特徵是主動脈瓣開口變窄，限制了血液從心臟流向身體其他部位。主動脈瓣狹窄市場主要是由人口老化所推動的，老年人更容易患這種疾病，因此需要在診斷和治療解決方案方面取得進展。市場解決方案的應用涵蓋多個領域，包括經導管主動脈瓣置換術(TAVR) 和外科手術，最終用途包括專科醫院和心臟護理中心。關鍵的成長要素包括醫療設備的技術進步、意識和診斷率的提高以及熟練醫療保健專業人員數量的增加。最近的監管核准趨勢和正在進行的臨床試驗也帶來了巨大的潛在機會，突顯了開發微創治療方法和改善病患監測系統等關鍵領域。公司可以透過投資研發以及與醫療保健提供者和技術公司合作來利用這些優勢。然而，該市場面臨治療方案成本高昂、監管要求嚴格以及新興地區進入有限等限制。創新已經成熟，可以開發具有更高耐用性和性能的下一代閥門系統，以及有助於最佳化患者追蹤和治療的數位健康解決方案。閥門材料的生物工程研究和成像技術的改進以實現更好的診斷可以提供重要的業務成長途徑。市場競爭激烈，各大公司都專注於併購和投資組合多元化以維持市場佔有率。地理擴張和新興市場開拓的策略聯盟也可能有效。不斷適應不斷變化的醫療保健法規並解決價格敏感性問題可以進一步增強市場佔有率和成長的永續性。

主要市場統計
基準年[2023] 82.3億美元
預測年份 [2024] 89.9億美元
預測年份 [2030] 156.7億美元
複合年成長率（%） 9.63%

市場動態：快速發展的主動脈瓣狹窄市場的關鍵市場洞察

主動脈瓣狹窄市場正因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 政府和私營部門努力改善醫療基礎設施和可近性
    • 增加創新治療方法和設備研發的投資
    • 主動脈瓣狹窄治療的優惠報銷政策和保險範圍
    • 醫療費用增加和病人接受手術的意願增加
  • 市場限制因素
    • 治療費用上漲
  • 市場機會
    • 微創治療的出現及其對主動脈瓣狹窄市場的潛在影響
    • 人工智慧在提高主動脈瓣狹窄診斷準確性和治療效果方面的作用
    • 創新的病人參與策略可增強主動脈瓣狹窄部分的照護和依從性
  • 市場挑戰
    • 嚴格的監管核准

波特五力：主動脈瓣狹窄市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解主動脈瓣狹窄市場的外部影響

外部宏觀環境因素在塑造主動脈瓣狹窄市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解主動脈瓣狹窄市場的競爭格局

主動脈瓣狹窄市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣主動脈瓣狹窄市場供應商的績效評估

FPNV 定位矩陣是評估主動脈瓣狹窄市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議繪製主動脈瓣狹窄市場的成功之路

主動脈瓣狹窄市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 政府和私營部門努力改善醫療基礎設施和可近性
      • 增加創新治療方法和設備研發的投資
      • 主動脈瓣狹窄治療的優惠報銷政策和保險範圍
      • 醫療費用增加和病人接受手術介入的意願增加
    • 抑制因素
      • 治療費用高
    • 機會
      • 新的微創治療方法及其對主動脈瓣狹窄市場的潛在影響
      • 人工智慧在提高主動脈瓣狹窄診斷準確性和治療效果方面的作用
      • 創新的病人參與策略，以增強主動脈瓣狹窄部分的照護和依從性
    • 任務
      • 嚴格的監管核准
  • 市場區隔分析
  • 波特五力分析
  • PESTLE分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章主動脈瓣狹窄市場（依瓣膜類型）

  • 機械閥
  • 組織瓣膜

第7章依手術類型分類的主動脈瓣狹窄市場

  • 微創手術
    • 機器人輔助手術
    • 胸腔鏡手術
  • 心臟直視手術
    • 全胸骨切開術
    • 部分胸骨切開術

第8章主動脈瓣狹窄市場：依最終用戶分類

  • 門診手術中心
  • 心臟中心
  • 醫院
  • 專科診所

第9章北美及南美主動脈瓣狹窄市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太主動脈瓣狹窄市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲主動脈瓣狹窄市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議
Product Code: MRR-535C629188E8

The Aortic Stenosis Market was valued at USD 8.23 billion in 2023, expected to reach USD 8.99 billion in 2024, and is projected to grow at a CAGR of 9.63%, to USD 15.67 billion by 2030.

Aortic stenosis (AS) is a cardiovascular condition characterized by the narrowing of the aortic valve opening, restricting blood flow from the heart to the rest of the body. The market for aortic stenosis is primarily driven by the aging population, as older adults are more susceptible to this condition, thus necessitating advancements in diagnostic and treatment solutions. The application of market solutions spans several areas, including transcatheter aortic valve replacement (TAVR) and surgical procedures, with end-use settings including specialty hospitals and cardiac care centers. Key growth factors include technological advancements in medical devices, increasing awareness and diagnosis rates, and a growing pool of skilled healthcare professionals. Recent regulatory approvals and ongoing clinical trials also present significant potential opportunities, highlighting key areas such as developing minimally invasive therapies and improved patient monitoring systems. Companies can capitalize on these by investing in R&D and partnerships with healthcare providers and technology firms. However, the market faces limitations such as high costs of treatment options, stringent regulatory requirements, and limited accessibility in developing regions. Innovations are ripe in the development of next-generation valve systems that offer enhanced durability and performance, as well as digital health solutions that can assist in patient tracking and treatment optimization. Research in bioengineering for valve materials and improved imaging technologies for better diagnosis can offer substantial business growth avenues. The market is competitive, with major players focusing on mergers and acquisitions and portfolio diversification to maintain market share. Strategic collaborations for geographical expansion and tapping into emerging markets can also be effective. Continuous adaptation to evolving healthcare regulations and addressing price sensitivity can further enhance market presence and growth sustainability.

KEY MARKET STATISTICS
Base Year [2023] USD 8.23 billion
Estimated Year [2024] USD 8.99 billion
Forecast Year [2030] USD 15.67 billion
CAGR (%) 9.63%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Aortic Stenosis Market

The Aortic Stenosis Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Government and private sector initiatives to improve healthcare infrastructure and accessibility
    • Growing investments in research and development for innovative aortic stenosis treatments and devices
    • Favorable reimbursement policies and insurance coverage for aortic stenosis treatments
    • Increasing healthcare expenditure and patient willingness to undergo surgical interventions
  • Market Restraints
    • High cost of treatment
  • Market Opportunities
    • Emerging minimally invasive treatments and their potential impact on the aortic stenosis market
    • The role of artificial intelligence in advancing diagnostic precision and treatment outcomes for aortic stenosis
    • Innovative patient engagement strategies to enhance care and compliance in the aortic stenosis segment
  • Market Challenges
    • Stringent regulatory approvals

Porter's Five Forces: A Strategic Tool for Navigating the Aortic Stenosis Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Aortic Stenosis Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Aortic Stenosis Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Aortic Stenosis Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Aortic Stenosis Market

A detailed market share analysis in the Aortic Stenosis Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Aortic Stenosis Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Aortic Stenosis Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Aortic Stenosis Market

A strategic analysis of the Aortic Stenosis Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Aortic Stenosis Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Balton Sp. z o.o., Biomerics, Boston Scientific, Bracco Diagnostics, Braile Biomedica, Cardiovalve, Claret Medical, CryoLife, Edwards Lifesciences, JenaValve Technology, Johnson & Johnson, LivaNova, Medtronic, Meril Life Sciences, Micro Interventional Devices, Peijia Medical, Tarilian Laser Technologies, Terumo, and Transseptal Solutions.

Market Segmentation & Coverage

This research report categorizes the Aortic Stenosis Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Valve Type, market is studied across Mechanical Valves and Tissue Valves.
  • Based on Surgery Type, market is studied across Minimally Invasive Surgery and Open Heart Surgery. The Minimally Invasive Surgery is further studied across Robot-Assisted Surgery and Thoracoscopic Surgery. The Open Heart Surgery is further studied across Full Sternotomy and Partial Sternotomy.
  • Based on End-User, market is studied across Ambulatory Surgery Centers, Cardiac Centers, Hospitals, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Government and private sector initiatives to improve healthcare infrastructure and accessibility
      • 5.1.1.2. Growing investments in research and development for innovative aortic stenosis treatments and devices
      • 5.1.1.3. Favorable reimbursement policies and insurance coverage for aortic stenosis treatments
      • 5.1.1.4. Increasing healthcare expenditure and patient willingness to undergo surgical interventions
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging minimally invasive treatments and their potential impact on the aortic stenosis market
      • 5.1.3.2. The role of artificial intelligence in advancing diagnostic precision and treatment outcomes for aortic stenosis
      • 5.1.3.3. Innovative patient engagement strategies to enhance care and compliance in the aortic stenosis segment
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory approvals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Aortic Stenosis Market, by Valve Type

  • 6.1. Introduction
  • 6.2. Mechanical Valves
  • 6.3. Tissue Valves

7. Aortic Stenosis Market, by Surgery Type

  • 7.1. Introduction
  • 7.2. Minimally Invasive Surgery
    • 7.2.1. Robot-Assisted Surgery
    • 7.2.2. Thoracoscopic Surgery
  • 7.3. Open Heart Surgery
    • 7.3.1. Full Sternotomy
    • 7.3.2. Partial Sternotomy

8. Aortic Stenosis Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgery Centers
  • 8.3. Cardiac Centers
  • 8.4. Hospitals
  • 8.5. Specialty Clinics

9. Americas Aortic Stenosis Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Aortic Stenosis Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Aortic Stenosis Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Balton Sp. z o.o.
  • 3. Biomerics
  • 4. Boston Scientific
  • 5. Bracco Diagnostics
  • 6. Braile Biomedica
  • 7. Cardiovalve
  • 8. Claret Medical
  • 9. CryoLife
  • 10. Edwards Lifesciences
  • 11. JenaValve Technology
  • 12. Johnson & Johnson
  • 13. LivaNova
  • 14. Medtronic
  • 15. Meril Life Sciences
  • 16. Micro Interventional Devices
  • 17. Peijia Medical
  • 18. Tarilian Laser Technologies
  • 19. Terumo
  • 20. Transseptal Solutions

LIST OF FIGURES

  • FIGURE 1. AORTIC STENOSIS MARKET RESEARCH PROCESS
  • FIGURE 2. AORTIC STENOSIS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL AORTIC STENOSIS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL AORTIC STENOSIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL AORTIC STENOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL AORTIC STENOSIS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL AORTIC STENOSIS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS AORTIC STENOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS AORTIC STENOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES AORTIC STENOSIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES AORTIC STENOSIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC AORTIC STENOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC AORTIC STENOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA AORTIC STENOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA AORTIC STENOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. AORTIC STENOSIS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. AORTIC STENOSIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. AORTIC STENOSIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL AORTIC STENOSIS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL AORTIC STENOSIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL AORTIC STENOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. AORTIC STENOSIS MARKET DYNAMICS
  • TABLE 7. GLOBAL AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL AORTIC STENOSIS MARKET SIZE, BY MECHANICAL VALVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL AORTIC STENOSIS MARKET SIZE, BY TISSUE VALVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL AORTIC STENOSIS MARKET SIZE, BY ROBOT-ASSISTED SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL AORTIC STENOSIS MARKET SIZE, BY THORACOSCOPIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL AORTIC STENOSIS MARKET SIZE, BY FULL STERNOTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL AORTIC STENOSIS MARKET SIZE, BY PARTIAL STERNOTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL AORTIC STENOSIS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL AORTIC STENOSIS MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL AORTIC STENOSIS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL AORTIC STENOSIS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS AORTIC STENOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES AORTIC STENOSIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC AORTIC STENOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. SOUTH KOREA AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. TAIWAN AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. THAILAND AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. VIETNAM AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA AORTIC STENOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 128. DENMARK AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. EGYPT AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. FINLAND AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. FRANCE AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. GERMANY AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. ISRAEL AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. ITALY AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. NETHERLANDS AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. NIGERIA AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. NORWAY AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. POLAND AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. QATAR AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. RUSSIA AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. SAUDI ARABIA AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH AFRICA AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 203. SPAIN AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 208. SWEDEN AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 213. SWITZERLAND AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. TURKEY AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 223. UNITED ARAB EMIRATES AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED KINGDOM AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 233. AORTIC STENOSIS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 234. AORTIC STENOSIS MARKET, FPNV POSITIONING MATRIX, 2023